ABSTRACT: Genes for five different 5-HT 3 receptor subunits have been identified. Most of the subunits have multiple isoforms, but two isoforms of the B subunits, brain-type 1 (Br1) and brain-type 2 (Br2) are of particular interest as they appear to be abundantly expressed in human brain, where 5-HT3B subunit RNA consists of approximately 75% 5-HT3Br2, 24% 5-HT3Br1, and <1% 5-HT3B. Here we use two-electrode voltage-clamp, radioligand binding, fluorescence, whole cell, and single channel patch-clamp studies to characterize the roles of 5-HT3Br1 and 5-HT3Br2 subunits on function and pharmacology in heterologously expressed 5-HT 3 receptors. The data show that the 5-HT3Br1 transcriptional variant, when coexpressed with 5-HT3A subunits, alters the EC 50 , n H , and single channel conductance of the 5-HT 3 receptor, but has no effect on the potency of competitive antagonists; thus, 5-HT 3 ABr1 receptors have the same characteristics as 5-HT 3 AB receptors. There were some differences in the shapes of 5-HT 3 AB and 5-HT 3 ABr1 receptor responses, which were likely due to a greater proportion of homomeric 5-HT 3 A versus heteromeric 5-HT 3 ABr1 receptors in the latter, as expression of the 5-HT3Br1 compared to the 5-HT3B subunit is less efficient. Conversely, the 5-HT3Br2 subunit does not appear to form functional channels with the 5-HT3A subunit in either oocytes or HEK293 cells, and the role of this subunit is yet to be determined. KEYWORDS: Serotonin, cys-loop, heteromeric, single channel 5-HT 3 receptors are members of the Cys-loop family of ligandgated ion channels that are responsible for fast excitatory and inhibitory synaptic transmission in the central and peripheral nervous systems. Other members of this family include the nACh, GABA, and glycine receptors, all of which share a common structural arrangement and are targets for a range of clinically important drugs.
5-HT
receptors are members of the Cys-loop family of ligandgated ion channels that are responsible for fast excitatory and inhibitory synaptic transmission in the central and peripheral nervous systems. Other members of this family include the nACh, GABA, and glycine receptors, all of which share a common structural arrangement and are targets for a range of clinically important drugs. 1−4 Cys-loop receptors consist of five subunits that surround a central ion-conducting pore. Each subunit can be divided into three functionally distinct regions that are termed the intracellular, transmembrane, and extracellular domains. The intracellular domain, whose structure is not yet known, is responsible for post-translational modulation by intracellular molecules and plays a role in channel conductance. 3, 5 The transmembrane domain consists of four membrane-spanning α-helices (M1−M4); M2 lines the pore, enabling ions to pass through the channel. In 5-HT 3 receptors, the pore is cation selective, and its opening results in a rapidly activating and then desensitizing inward current that depolarizes the cell. The extracellular domain contains the ligand binding sites for agonist and competitive antagonists and these are formed by the convergence of six amino acid loops at the interface of two adjacent subunits. Three loops (A−C) arise from the principal subunit and three (D−F) from the complementary subunit. The amino acids responsible for interacting with ligands vary according to the ligand and receptor being studied, but all binding pockets possess three to five aromatic residues that contribute to an "aromatic box" which is important for binding ligands.
To date, genes for five 5-HT 3 receptor subunits have been identified (5-HT3A−5-HT3E) in humans. 6 Only 5-HT3A subunits can form functional homomeric receptors, and the structure of the mouse 5-HT 3 A receptor has recently been solved to high resolution. 7 The other subunits can combine with 5-HT3A to form heteromeric complexes, but, apart from receptors expressing 5-HT3A and 5HT3B subunits (5-HT 3 AB receptors), these have not been extensively investigated. 8−10 Most of the subunits have multiple isoforms, but two isoforms of the 5-HT3B subunits, brain-type 1 and brain-type 2 (called here 5-HT3Br1 and 5-HT3Br2 rather than 5-HT3BBr1/2), are of particular interest as their RNAs are abundantly expressed in human brain. 11 These authors reported that in brain less than 1% of the 5-HT3B subunit RNA coded for the conventional 5-HT3B subunit, while the remaining B-subunit RNA was Special Issue: Serotonin Research accounted for by approximately 75% 5-HT3Br2 and 24% 5-HT3Br1. There is therefore the potential that 5-HT 3 AB receptors in the brain have distinct properties to those in other regions. As 5-HT 3 receptor-selective agents have a range of therapeutic applications it is important to better understand the consequences of incorporating these subunits on the pharmacology and physiology of these receptors.
The aim of this study was to assess the functional role of 5-HT 3 AB receptors containing 5-HT3Br1 or 5-HT3Br2 subunits, which differ only in their N-terminal sequences (Figure 1 ) compared to the originally described 5-HT3B subunit. We do this using a combination of two-electrode voltage-clamp, radioligand binding, fluorescence, and whole cell and single channel patch-clamp studies.
■ RESULTS AND DISCUSSION
Characterization of 5-HT 3 A and 5-HT 3 AB Receptors. Application of 5-HT to Xenopus oocytes expressing homomeric or heteromeric receptors produced rapidly activating inward currents that desensitized over the time-course of the application (Figure 2) . The shape of the responses elicited by 5-HT 3 A and 5-HT 3 AB receptors differed due to faster desensitization of the latter. Concentration−response curves for 5-HT 3 A and 5-HT 3 AB receptors also showed differences in 5-HT EC 50 , which was increased in 5-HT 3 AB compared to 5-HT 3 A receptors, and Hill slope, which was reduced (Table 1, Figure 2 ) as previously published.
8−10 Similar differences in EC 50 and n H were observed for receptors expressed in HEK293 cells, with functional responses measured using a fluorescent membrane potential sensitive dye; EC 50 was increased and n H decreased in 5-HT 3 AB compared to 5-HT 3 A receptors. Here again there were differences in the shape of the responses: 5-HT 3 A receptor responses peaked and returned toward baseline over the course of the experiment, while 5-HT 3 AB responses peaked more slowly and only decreased toward baseline at lower 5-HT concentrations ( Figure 3 ). Characterization of 5-HT 3 ABr1 Receptors in Oocytes. Coexpression of 5-HT3Br1 with 5-HT3A subunits produced currents in Xenopus oocytes with concentration−response parameters that were similar to 5-HT 3 AB receptors. This was expected as the amino acid composition of the 5-HT3Br1 Figure 1 . Alignment of the N-terminal region of 5-HT3B, 5-HT3Br1, and 5-HT3Br2 subunits. 5HT3Br1 subunits differ from 5-HT3B subunits only in the extreme N-terminus, while 5HT3Br2 has ∼100 fewer amino acids and is missing the β1 and β2/loop D regions. Differences in the subunits are due to alternative splicing so the remaining sequences are identical. 
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Research Article subunit is very similar to that of the 5-HT3B subunit, with the only difference being a region at the extreme N-terminus of the subunit (Figure 1 ). This region is likely to be predominantly, if not solely, part of the signal sequence, and thus is not likely to be expressed in the mature protein. However, the shape of the responses in 5-HT 3 ABr1 receptors differed from those in 5-HT 3 AB receptors, being somewhat intermediate between those of 5-HT 3 A and 5-HT 3 AB receptors ( Figure 2 ), with fast desensitization at high 5-HT concentration but slower desensitization at low concentrations. These differences likely arise as these cells can express both homomeric (5-HT 3 A) and heteromeric receptors (5-HT 3 AB/Br1), and the proportions of these may differ depending on which B subunit is being expressed. It is also possible that differential B subunit expression could cause different stoichiometries, and different characteristics, as is the case in certain nACh receptors, 12 although there is currently no evidence for this.
Characterization of Table  2) .
The 5-HT3Br1 subunit, however, was expressed and/or incorporated into functional receptors over a different time course and concentration range when compared to the 5-HT3B subunit: higher concentrations and a longer period after transfection were needed to obtain similar effects. Figure 4 shows the effects on receptor parameters determined 2 or 3 days post transfection. Analysis of data obtained 2 days post transfection with 2 or 20 ng 5-HT3B subunit cDNA (both combined with 20 ng 5-HT3A subunit cDNA) revealed receptor characteristics that were consistent with 5-HT 3 AB receptors, but such characteristics were not apparent in cells transfected with 5-HT3Br1 subunit cDNA until at least 3 days post transfection and required >20 ng 5-HT3Br1 subunit cDNA. These data show that the signal sequence has a significant effect on expression and/or subsequent incorporation of the 5-HT3Br1 subunit into functional receptors, and support the expression hypothesis proposed above (different relative expression levels of homomeric and heteromeric receptors) to explain the different traces in 5-HT 3 AB and 5-HT 3 ABr1 receptors. Given these data, a study of the levels of expression of the 5-HT3Br1 subunit protein in brain tissues would be worthwhile, as the data showing high levels of 5-HT3Br1 subunit RNA in neurones may not provide an accurate picture of the relative proportions of different types of 5-HT 3 receptor subunits being expressed. (Table 2 ). We also determined K i values for a range of competitive antagonists, and all competed with similar affinities with a rank order of potency of palonosetron > granisetron > MDL-72222 > mCPBG > d-TC ( Figure 5 ). These data are consistent with previous studies on 5-HT 3 A and 5-HT 3 AB receptors that have demonstrated similar antagonist affinities for a range of compounds, despite some biophysical differences between 
Research Article homomeric and heteromeric receptors. This similarity can be readily explained if the binding site for these ligands is at an interface between two adjacent 5-HT3A subunits, which is consistent with the reduced Hill slope of 5-HT concentration− response curve at heteromeric receptors, and our previous findings that mutations to residues in either the principal or complementary face of the 5-HT3B-subunit binding site do not alter ligand binding. 13 Indeed there is good evidence from FRET studies that the orthosteric binding site is located between two adjacent 5-HT3A subunits in both 5-HT 3 A and 5-HT 3 AB receptors. 14 To further probe any differences between 5-HT 3 AB and 5-HT 3 ABr1 receptors we explored their single channel currents. Single-channel recordings from cell-attached patches of HEK293 cells expressing 5-HT 3 AB and 5-HT 3 ABr1 receptors (1:3 A:B or Br1 ratio) in the presence of 10 μM 5-HT revealed that activation occurred in bursts composed of closely spaced openings separated by brief closed periods. The mean amplitude of single channel openings at −70 mV was 1.95 ± 0.06 pA and 2.17 ± 0.15 pA for 5-HT 3 AB and 5-HT 3 ABr1 receptors respectively (n = 3), and increased with the decrease of membrane potential (2.9 ± 0.2 and 3.2 ± 0.3 pA, respectively, at −100 mV; Figure 6 ). The relationship between membrane potential and mean amplitude of the events yielded an estimated conductance of 30 ± 1.2 pS and 33 ± 1.1 pS for 5-HT 3 AB and 5-HT 3 ABr1 receptors, respectively (Figure 7) . For both receptors, open time histograms were fitted by two exponential components with no significant differences in the mean duration of each component ( Figure 6 ). The mean durations of both components at −100 mV were 3.9 ± 0.9 ms and 0.14 ± 0.05 ms for 5-HT 3 AB (n = 6), and 3.6 ± 0.6 ms and 0.11 ± 0.03 ms for 5-HT 3 ABr1 (n = 4) (p > 0.1). In addition, the mean burst duration did not differ between 5-HT 3 AB (13.5 ± 4.0 ms, n = 6) and 5-HT 3 ABr1 receptors (14.2 ± 5.20 ms, n = 4) (p > 0.1). Thus, the data show there are no significant differences between single-channel properties of 5-HT 3 those obtained from 5-HT 3 A receptors. These data could indicate that the 5-HT3Br2 subunit is being incorporated into receptors, but has no effect on receptor parameters. To test this, we examined the potency of picrotoxinin. This compound acts in the pore and has differing potencies at 5-HT 3 A and 5-HT 3 AB receptors (IC 50 s of 11 and 62 μM respectively) due to the different pore lining residues contributed by the 5-HT3B (and similarly the 5-HT3Br1 and 5-HT3Br2) subunits. 15 Here picrotoxinin had an IC 50 of 17 μM (pIC 50 = 4.77 ± 0.14, n = 3), which is not significantly different from the value obtained for 5-HT 3 A receptors (pIC 50 = 4.97 ± 0.12, n = 13), suggesting the 5-HT3Br2 subunit was not part of the functional receptor.
Characterization of 5-HT 3 ABr2 Receptors in HEK Cells. Coexpression of 5-HT 3 A and 5-HT 3 Br2 receptor subunits in HEK cells analyzed using membrane potential fluorescent dye revealed concentration response parameters and shapes of traces that were indistinguishable from those of 5-HT 3 A receptors ( Figure 3 ). Macroscopic currents measured in the whole cell configuration from cells transfected with 5-HT3A and 5-HT3Br2 subunits (1:9 ratio) were similar to those of 5-HT 3 A receptors and clearly different to those of 5-HT 3 AB receptors (Figure 8) .
Moreover, despite the detection of whole-cell macroscopic currents in 5-HT 3 ABr2 transfected cells, no single channel events were detected in 30 different patches from green cells and two different transfections (ratios 1:3 and 1:9 of 5-HT3A:5-HT3Br2 subunits) (Figure 8 ). These data are therefore consistent with functional expression of solely homomeric 5-HT 3 A receptors, whose conductance is too low to allow detection of single channel openings. 16 It has been shown that only after the introduction of the triple QDA mutation at determinants of ion conductance of the 5-HT3A subunit, which mimics the amino acids found in the 5-HT3B subunit, single-channel openings of 5-HT 3 A receptors can be detected under the present recording conditions. 16−18 Incorporation of even one 5-HT3Br2 subunit into receptors should permit the detection of such events, as this subunit possesses the high-conductance triple QDA motif that can be readily detected even when only a single subunit is present. 19, 20 This apparent lack of incorporation of the 5-HT3Br2 subunit into functional heteromeric receptors is likely to be due to its unusual sequence: this subunit is missing the β1-β2 loop and loop D, which are essential for gating. 21 The considerable abundance of 5-HT 3 Br2 mRNA in the brain, however, suggests it is important. 11 This subunit may therefore have some other role, and warrants further investigation.
■ CONCLUSION
This study demonstrates that the 5-HT3Br1 transcriptional variant of the 5-HT3B subunit can contribute to the functional properties of heteromeric receptors in a similar manner to the 
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Research Article originally characterized 5-HT3B subunit, altering the EC 50 , n H , and single channel conductance of the 5-HT 3 A receptor. Its expression levels, however, differ significantly from those of the canonical 5-HT3B subunits in heterologous systems. Conversely the 5-HT3Br2 subunit does not form functional channels with the 5-HT3A subunit in either oocytes or HEK cells. Its physiological role is yet to be determined.
■ METHODS
Materials. All cell culture reagents were obtained from Gibco (Invitrogen Ltd., Paisley, U.K.), except fetal calf serum which was from Labtech International (Ringmer, U.K.). Human 5-HT 3 A (accession number: P46098) and 5-HT 3 B (O95264) receptor subunit cDNA was kindly gifted by Prof J. A. Peters (University of Dundee, U.K.). 5-HT3Br1 and 5-HT3Br2 subunit cDNAs were generated by Quikchange mutagenesis.
Oocyte Maintenance. Xenopus laevis oocyte-positive females were purchased from NASCO (Fort Atkinson, WI) and maintained according to standard methods. Harvested stage V−VI Xenopus oocytes were washed in four changes of Ca-free ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, pH 7.5), defolliculated in 1.5 mg mL −1 collagenase Type 1A for approximately 2 h, washed again in four changes of ND96, and then stored in ND96 containing 2.5 mM sodium pyruvate, 50 mM gentamycin, and 0.7 mM theophylline.
HEK293 Cell Culture. Human embryonic kidney (HEK) 293 cells were maintained on 90 mm tissue culture plates at 37°C and 7% CO 2 in a humidified atmosphere. They were cultured in DMEM:F12 with GlutaMAX I media (Dulbecco's modified Eagle's Medium/Nutrient Mix F12 (1:1), Invitrogen, Paisley, U.K.) containing 10% fetal calf serum. Cells in 90 mm dishes were transfected using polyethylenimine (PEI). Then 30 μL of PEI (1 mg/mL), 4 μL of cDNA (1 mg/mL) and 1 mL of DMEM were incubated for 10 min at room temperature, added dropwise to a 80−90% confluent plate, and incubated for 2−3 days. For Flexstation studies, cells were transferred to 96-well plates and allowed to adhere overnight before use.
Receptor Expression. cDNA was cloned into pGEMHE for oocyte expression, and pcDNA3.1 (Invitrogen, Paisley, U.K.) for expression in HEK 293 cells. Mutagenesis (Figure 1 ) was performed using QuikChange (Agilent Technologies Inc., Santa Clara, CA). cRNA was in vitro transcribed from linearized pGEMHE cDNA template using the mMessage mMachine T7 Transcription kit (Ambion, Austin, TX). 5-HT3A was linearized with SphI and 5-HT3B cDNA with NheI. Stage V and VI oocytes were injected with 50 nL of ∼400 ng μL −1 cRNA, and currents were recorded 1−4 days postinjection. Ratios of 1:3 (5-HT3A:5-HT3B/5-HT3Br1/5-HT3Br2) were used for the expression of heteromeric receptors unless otherwise stated. These levels were previously found to be optimal for 5-HT 3 AB receptor expression, as ratios ≤1:1 resulted in more 5-HT 3 A receptorlike responses and ≥1:10 showed poorer total receptor expression.
Fluorometric Analysis. This was as previously described. 22 In brief, fluorescent membrane potential dye (Membrane Potential Blue kit, Molecular Devices) was diluted in Flex buffer (10 mM HEPES, 115 mM NaCl, 1 mM KCl, 1 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM glucose, pH 7.4) and 100 μL added to each well of transfected cells. The cells were incubated at 37°C for 45 min, and then fluorescence was measured in a FlexStation (Molecular Devices) at 2 s intervals for 200 s. 5-HT (Sigma) was added to each well after 20 s. Analysis and curve fitting was performed using Prism (GraphPad Software, San Diego, CA, www.graphpad.com).
TEVC Electrophysiology. Using two electrode voltage-clamp, Xenopus oocytes were clamped at −60 mV using an OC-725 amplifier (Warner Instruments, Hamden, CT), Digidata 1322A, and the Strathclyde Electrophysiology Software Package (Department of Physiology and Pharmacology, University of Strathclyde, UK).
Currents were recorded at a frequency of 5 kHz and filtered at 1 kHz. Microelectrodes were fabricated from borosilicate glass (GC120TF-10, Harvard Apparatus, Edenbridge, Kent, U.K.) using a one stage horizontal pull (P-87, Sutter Instrument Company, Novato, CA) and filled with 3 M KCl. Pipet resistances ranged from 1.0 to 2.0 MΩ. Oocytes were perfused with saline at a constant rate of 12 mL min −1 . Drug application was via a simple gravity fed system calibrated to run at the same rate. Extracellular saline contained (mM), 96 NaCl, 2 KCl, 1 MgCl 2 , and 5 mM HEPES; pH 7.4 with NaOH).
Concentration−response data for each oocyte was normalized to the maximum current for that oocyte, and analysis and curve fitting was performed using Prism.
Whole-Cell Patch-Clamp Electrophysiology. Macroscopic current recordings were recorded in the whole-cell configuration essentially as described before. 17 For whole-cell recordings, the perfusion system consisted of solution reservoirs, manual switching valves, a solenoid-driven pinch valve, and two tubes (inner diameter, 0.3 mm) oriented at 90°inserted into the culture dish (modified from ref 23) . One tube contained extracellular solution (ECS) without agonist (normal solution), and the other contained ECS with of 5-HT (test solution). A series of 1.5 s pulses of ECS containing 100 μM 5-HT were applied at 15 s intervals. The pipet solution contained 134 mM KCl, 5 mM EGTA, 1 mM MgCl 2 , and 10 mM HEPES, pH 7.3. The extracellular solution contained 150 mM NaCl, 5.6 mM KCl, 0.5 mM CaCl 2 , and 10 mM HEPES, pH 7.3. Macroscopic currents were recorded at an applied potential of −50 mV, filtered at 5 kHz, and digitized at 20 kHz. Data analysis was performed using the IgorPro software (Wavemetrics). For each experiment, three to five individual records were aligned at the point at which the current reached 50% of maximum, and expressed as their average. The solution exchange time was estimated by placing an open pipet at the cell position, and switching from normal bath solution to a diluted (1:1 with water) bath solution. Typical times varied between 1 and 2 ms.
Single-Channel Patch-Clamp Recordings. Single-channel recordings were obtained in the cell-attached patch configuration essentially as described before. 17 The bath and pipet solutions contained 142 mM KCl, 5.4 mM NaCl, 0.2 mM CaCl 2 , and 10 mM HEPES, pH 7.4. Single-channel currents were recorded and low-pass filtered to 10 kHz using an Axopatch 200 B patch-clamp amplifier (Molecular Devices), digitized at 5 μs intervals, and detected by the half a mplitude threshold criterion using the program TAC (Bruxton Corporation). Open-time histograms were fitted by the sum of exponential functions by maximum likelihood using the program TACFit (Bruxton Corporation). Bursts were identified as a series of closely separated openings (more than five) preceded and followed by closings longer than a critical duration. Radioligand Binding. Transfected HEK 293 cells were scraped into 1 mL of ice-cold HEPES buffer (10 mM, pH 7.4) and frozen. After thawing, they were washed with HEPES buffer and resuspended, and then 50 μg of cell membranes was incubated in 0.5 mL of HEPES buffer containing 1 nM [ 3 H]granisetron (∼K d ) in a total volume of 500 μL. Nonspecific binding was determined using 1 mM quipazine or 10 μM d-tubocurarine, giving the same result. For competition binding (8 point), reactions were incubated for at least 1 h at 4°C. Reactions were terminated by vacuum filtration using a Brandel cell harvester onto GF/B filters presoaked in 0.3% polyethylenimine. Radioactivity was determined by scintillation counting using a Beckman BCLS6500 instrument (Fullerton, CA). Individual competition binding experiments were analyzed by iterative curve fitting using Prism.
Statistical Analysis. Statistical analysis was performed using Prism using Student's t test or one-way ANOVA as appropriate, and p < 0.05 was taken as statistically significant.
